Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of empagliflozin 25 mg film-coated tablets in healthy Thai volunteers
TCTR20210324005Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of empagliflozin (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 1 more. Started May 2021; status: completed.
02
Drugs
empagliflozin
Beyond the preview
Go deeper on TCTR20210324005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210324005.